Chronic treatment with a selective inhibitor of casein kinase I delta/epsilon yields cumulative phase delays in circadian rhythms.
BACKGROUND
Casein kinase I epsilon/delta phosphorylates certain clock-related proteins as part of a complex arrangement of transcriptional/translational feedback loops that comprise the circadian oscillator in mammals. Pharmacologic inhibition leads to a delay of the oscillations with the magnitude of this effect dependent upon the timing of drug administration.


OBJECTIVE
Earlier studies by our lab described the actions of a selective CKI epsilon/delta inhibitor, PF-670462, on circadian behavior following acute dosing; the present work extended these studies to chronic once-daily treatment.


METHODS
Gross motor activity was used to estimate the circadian rhythms of rats maintained under a 12 L:12 D cycle. PF-670462, 10 or 30 mg/kg/day s.c., was administered once daily for 20 days either at ZT6 or ZT11 (i.e., 6 or 11 h after light onset).


RESULTS
Chronic administration of PF-670462, performed at a fixed time of day, produced delays in the activity onsets of rats that cumulated with the duration of dosing. Dosing at ZT11 yielded more robust delays than dosing at ZT6 in keeping with earlier phase-response analyses with this agent.


CONCLUSIONS
The magnitude of the shifts in activity onsets achieved with chronic dosing of PF-670462 appears to be a function of the dose and the previously established phase relationship. Its cumulative effect further suggests that the pharmacodynamic t (1/2) of the drug greatly exceeds its pharmacokinetic one. Most importantly, these changes in circadian behavior occurred in the presence of a fixed L:D cycle, confirming the drug to be a robust modulator of circadian phase in the presence of the natural zeitgeber.
Sprouse
Jeffrey
J
Neuroscience Research Unit, Pfizer Global Research & Development, Groton, CT 06340, USA. JSPR@Lundbeck.com
Reynolds
Linda
L
Kleiman
Robin
R
Tate
Barbara
B
Swanson
Terri A
TA
Pickard
Gary E
GE
D000818:Animals; D001683:Biological Clocks / Q000187:drug effects; D048149:Casein Kinase 1 epsilon / Q000037:antagonists & inhibitors*; D048148:Casein Kinase Idelta / Q000037:antagonists & inhibitors*; D002940:Circadian Rhythm / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011743:Pyrimidines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors
D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; C522839:PF-670462; D048149:Casein Kinase 1 epsilon; D048148:Casein Kinase Idelta
Nature. 2005 Mar 31;434(7033):640-4
15800623
Mol Cell Biol. 2002 Mar;22(6):1693-703
11865049
Sleep Med. 2007 Sep;8(6):623-36
17383938
J Pharmacol Exp Ther. 2007 Aug;322(2):730-8
17502429
Cell. 2001 Dec 28;107(7):855-67
11779462
Prog Brain Res. 2006;153:341-60
16876585
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4453-8
19255424
Arch Gerontol Geriatr. 2000 Aug 1;31(1):65-76
10989165
Mol Cell Biol. 2005 Apr;25(7):2795-807
15767683
Nat Rev Genet. 2008 Oct;9(10):764-75
18802415
J Biol Rhythms. 2006 Dec;21(6):494-506
17107939
Cold Spring Harb Symp Quant Biol. 2007;72:477-82
18419307
Cold Spring Harb Symp Quant Biol. 2007;72:421-9
18419300
Am J Physiol. 1984 Mar;246(3 Pt 2):R299-304
6703083
Mol Cell Biol. 2009 Jul;29(14):3853-66
19414593
Diab Vasc Dis Res. 2008 Jun;5(2):89-95
18537095
Int Clin Psychopharmacol. 2006 Feb;21 Suppl 1:S11-5
16436934
Psychopharmacology (Berl). 2009 Jul;204(4):735-42
19277609
Ann Med. 2006;38(8):552-9
17438670
Am J Med Genet. 2002 May 8;114(4):391-406
11992561
Mol Cell Biol. 2000 Jul;20(13):4888-99
10848614
Eur Neuropsychopharmacol. 2006 Feb;16(2):93-100
16249073
J Neuroendocrinol. 2008 Jun;20(6):812-9
18601704
Endocrinology. 2007 Dec;148(12):5624-34
17901233
J Biol Rhythms. 2008 Feb;23(1):3-15
18258753
Int Clin Psychopharmacol. 2002 Sep;17(5):239-47
12177586
J Biol Chem. 2002 May 10;277(19):17248-54
11875063
Physiol Res. 2008;57 Suppl 3:S139-S148
18481906
Chronobiol Int. 2007;24(2):195-213
17453843
Biol Psychiatry. 1978 Jun;13(3):335-51
667233
J Pharmacol Exp Ther. 2009 Aug;330(2):430-9
19458106
Int Clin Psychopharmacol. 2007 Oct;22 Suppl 2:S1-8
17917561
Cold Spring Harb Symp Quant Biol. 2007;72:75-83
18419264
Curr Opin Microbiol. 2006 Dec;9(6):579-87
17064954
Cold Spring Harb Symp Quant Biol. 2007;72:167-76
18419274
Ann N Y Acad Sci. 2008;1129:358-70
18591495
J Neurosci. 1995 Mar;15(3 Pt 2):2109-22
7534344
J Neurosci Res. 2001 Jun 15;64(6):612-6
11398185
Sleep Med Rev. 2005 Feb;9(1):25-39
15649736
PLoS Genet. 2008 May 30;4(5):e1000040
18516223
Sleep Med Rev. 2009 Feb;13(1):47-60
18845459
J Clin Psychopharmacol. 2004 Aug;24(4):456-9
15232344
J Cell Sci. 2006 Dec 1;119(Pt 23):4793-5
17130292
J Genet. 2008 Dec;87(5):467-71
19147935